Enhancing Organizational Capacity and Provider Readiness to Treat OUD With Buprenorphine/Naloxone: Clinical Application of a MOUD

Open this course Estimated time to complete activity: 1.25 hours Audience: Providers
Credits Available: AMAAAPAANCCASWBACPECPH UAN #JA4008162-9999-20-2407-H01-P
Activity Release Date: November 2, 2020 Expiration Date: November 1, 2021

This module focuses on enhancing organizational capacity and provider readiness to treat opioid use disorder with buprenorphine-naloxone through reviewing how to recognize and diagnose OUD and differing treatment methodologies.

Learning Objectives

  • Detail how to treat OUD with buprenorphine/naloxone
  • List at least two justifications for the use of combination buprenorphine/naloxone as the standard of care for general use
  • List at least three methods for establishing community partnerships and promoting MOUD services in general medical settings
  • Describe the key principles of the medication first model
  • Discuss the benefit of adding psychosocial support to the treatment of patients receiving MOUD
  •  Employ appropriate urine toxicology strategies
  • Outline treatment considerations for patients with co-occurring psychiatric disorders
  • Explain how to conduct a Telehealth session for treatment of OUDs

Note:

Jointly provided by Postgraduate Institute for Medicine and HealthHIV